Judi is transforming global clinical development across 20 therapeutic areas and countless indications.

Jun 5, 2024

3

 min read

From Pediatric Sickle Cell to Mitochondrial Disease, Rare Disease research is powered by Judi

Jun 5, 2024

3

 min read

The escalating prevalence of cardiometabolic diseases significantly underscores their importance in the realm of global clinical trials.

Jun 5, 2024

3

 min read

Supporting 5,200 patient eligibility determinations across 900 Oncology trials in every phase

Jun 5, 2024

3

 min read

Prominent clinical-stage biotech combines Judi for Eligibility and Judi for Adjudication

Feb 20, 2024

5

 min read

Prominent international biotech partners with Judi by AG Mednet and Medrio for holistic solution to remote monitoring and electronic data capture (EDC) on three-year global clinical program of 10 studies

From Data Capture to Data Liberation

Prominent clinical-stage biotech combines Judi for Eligibility and Judi for Adjudication on pivotal Phase 2 CAR-T oncology trial with over 600 endpoints

International biopharma sponsor and partner CRO maximize flexibility of Judi for DSMB for Phase 2 multinational clinical program with over 100 patients and 60 sites

US-based biopharma leverages scalability of Judi for Imaging on three concurrent pulmonary oncology trials